Improving biophysical properties of a bispecific antibody scaffold to aid developability
Open Access
- 1 September 2013
- journal article
- Published by Taylor & Francis in mAbs
- Vol. 5 (5) , 646-654
Abstract
While the concept of Quality-by-Design is addressed at the upstream and downstream process development stages, we questioned whether there are advantages to addressing the issues of biologics quality early in the design of the molecule based on fundamental biophysical characterization, and thereby reduce complexities in the product development stages. Although limited number of bispecific therapeutics are in clinic, these developments have been plagued with difficulty in producing materials of sufficient quality and quantity for both preclinical and clinical studies. The engineered heterodimeric Fc is an industry-wide favorite scaffold for the design of bispecific protein therapeutics because of its structural, and potentially pharmacokinetic, similarity to the natural antibody. Development of molecules based on this concept, however, is challenged by the presence of potential homodimer contamination and stability loss relative to the natural Fc. We engineered a heterodimeric Fc with high heterodimeric specificity that also retains natural Fc-like biophysical properties, and demonstrate here that use of engineered Fc domains that mirror the natural system translates into an efficient and robust upstream stable cell line selection process as a first step toward a more developable therapeutic.Keywords
This publication has 49 references indexed in Scilit:
- Efficient generation of stable bispecific IgG1 by controlled Fab-arm exchangeProceedings of the National Academy of Sciences, 2013
- Disulfide bond structures of IgG moleculesmAbs, 2012
- A novel bispecific antibody format enables simultaneous bivalent and monovalent co-engagement of distinct target antigensmAbs, 2011
- Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodiesProceedings of the National Academy of Sciences, 2011
- Development of a Two-part Strategy to Identify a Therapeutic Human Bispecific Antibody That Inhibits IgE Receptor SignalingJournal of Biological Chemistry, 2010
- Enhancing Antibody Fc Heterodimer Formation through Electrostatic Steering EffectsJournal of Biological Chemistry, 2010
- Contributions of a disulfide bond to the structure, stability, and dimerization of human IgG1 antibody CH3 domainProtein Science, 2008
- Comparison of multiple Amber force fields and development of improved protein backbone parametersProteins: Structure, Function, and Bioinformatics, 2006
- Folding and Oxidation of the Antibody Domain CH3Journal of Molecular Biology, 2002
- Stable heterodimers from remodeling the domain interface of a homodimer using a phage display libraryJournal of Molecular Biology, 1997